Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pain × Doxycycline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Non-Hodgkin 2 Immunoglobulin Light-chain Amyloidosis 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Amyloidosis 2 Waldenstrom Macroglobulinemia 1 Tissue Adhesions 1 Skin Toxicity 1 Sezary Syndrome 1 Ras-wildtype Colorectal Cancer 1 Polyps 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Pain 1 Myoma 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Head and Neck Neoplasms 1 Exanthema 1 Endometritis 1 Colorectal Neoplasms 1 Amyloidosis, Familial 1 Advanced Malignant Neoplasm 1 AA amyloidosis 1

Interventions

Analgesia 6 Morphine 5 nabiximols 3 Pregabalin 3 Oxycodone 3 Fentanyl 3 ziconotide 2 Surveys and Questionnaires 2 Saline Solution 2 Radiofrequency Ablation 2 Methadone 2 Lidocaine 2 Ibandronic Acid 2 Duloxetine Hydrochloride 2 Docetaxel 2 trimebutine 3-thiocarbamoylbenzenesulfonate 1 tanezumab 1 tandutinib 1 siltuximab 1 resiniferatoxin 1 incobotulinumtoxinA 1 imisopasem manganese 1 fulranumab 1 erenumab 1 cyclobenzaprine 1 caffeine, sodium benzoate drug combination 1 Therapeutics 1 Tapentadol 1 Sulindac 1 Soybean Proteins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01847976 2019-09-06

OTT12-05

Ottawa Hospital Research Institute

Phase 2 Completed

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡